Vaccination programme delivery
Please check this page content as updates and information continues to change.
About the COVID-19 Vaccination Programme
COVID-19 vaccination: information for healthcare practitioners (gov.uk)
21 December 2021
UK COVID-19 Response: Autumn and Winter Plan 2021
9 November 2021
Isle of Man Government Strategy for COVID-19 (covid19.gov.im)
September 2021
COVID-19 Isle of Man Winter Plan
12 November 2021
Training resources
COVID-19 vaccination training slide set [PowerPoint download] (gov.uk)
Isle of Man Government health professionals
Should visit E-Learn Vannin (Internal site – available to Government Employees only)
Prospectus Section 6 – Complete the COVID-19 Training
If you do not already have access to this training area or experience any problems whilst completing this training, please visit our eLearn Vannin page for more details.
If you do not have access to the Isle of Man Government E-Learn Vannin training tool, please visit E Learning for Health Care online training tool at COVID-19 vaccination e-learning programme (gov.uk).
COVID-19: vaccinator training recommendations (gov.uk)
4 October 2021
COVID-19: vaccinator competency assessment tool (gov.uk)
16 March 2021
Guidance
About the vaccines
Use of human and animal products in vaccines (gov.uk)
15 January 2021
During pregnancy
The safety of COVID-19 vaccines when given in pregnancy (gov.uk)
30 April 2021
For prisons and secure settings
COVID-19 vaccination: resources for secure settings (gov.uk)
24 August 2021
For Employers
COVID-19 vaccination: guide for employers (gov.uk)
12 July 2021
For schools
COVID-19: provision of immunisation sessions for outbreaks in schools (gov.uk)
22 September 2021
For those Living Overseas
COVID-19 vaccines if you live abroad (gov.uk)
30 June 2021
COVID-19 vaccinations received overseas (gov.uk)
16 December 2021
Posters for display
COVID-19 vaccination and pregnancy poster (print version)
8 October 2021
COVID-19 vaccination: vaccine product information (gov.uk)
14 June 2021
Green book
Chapter 14a
COVID-19: the green book, chapter 14a (gov.uk)
12 January 2022
Includes information on:
- the coronavirus (COVID-19) vaccines
- the dosage and schedule for the UK
- recommendations for the use of the vaccine
Chapter 8
Vaccine safety and adverse events following immunisation: the green book, chapter 8 (gov.uk)
20 March 2013
Chapter 2
Consent: the green book, chapter 2 (gov.uk)
18 June 2021
MHRA and Coronavirus Yellow Card reporting
The MHRA is working closely with DHSC and other healthcare partners on COVID-19.
They are prioritising work including:
- supporting and authorising the development of vaccines
- clinical trials of new medicines
- managing the supply of medicines and healthcare products
They also provide information to patients, manufacturers and healthcare professionals through our established information channels and alert systems.
For guidance visit: MHRA guidance on coronavirus (COVID-19) (gov.uk)
Report any suspected side effects of vaccines and medicines through the Yellow Card scheme.
By calling 0800 731 6789; or registering and downloading the Yellow Card app; or online.
MHRA regular reports
The MHRA Weekly report covering adverse reactions to approved COVID-19 vaccines are published on a Thursday.
Also see the COVID-19 vaccination and rare side effects.
COVID-19 variants identified in the UK
COVID-19 variants: genomically confirmed case numbers
10 December 2021
Investigation of SARS-CoV-2 variants of concern: variant risk assessments
10 December 2021
Investigation of SARS-CoV-2 variants of concern: routine variant data update
17 September 2021
Oral statement to update on the Omicron variant
29 November 2021
Investigation of SARS-CoV-2 variants of concern: technical briefings
17 September 2021
Surveillance
Local Vaccination delivery: COVID-19 vaccine statistics (covid19.gov.im)
Regularly updated
Guidance: COVID-19 vaccination in pregnancy surveillance
25 November 2021
Guidance: Monitoring reports of the effectiveness of COVID-19 vaccination
7 January 2022
Research and analysis: COVID-19 vaccine weekly surveillance reports (weeks 39 to 2, 2021 to 2022)
13 January 2022
Research and analysis: COVID-19 vaccine surveillance reports (weeks 19 to 38)
23 September 2021
Guidance: PHE monitoring of the effectiveness of COVID-19 vaccination
14 September 2021
Research and analysis: COVID-19 vaccine monitoring reports
14 January 2021
Guidance: COVID-19: enhanced surveillance of cases in vaccinated individuals
11 November 2021
Guidance: COVID-19: vaccine surveillance strategy
29 March 2021
Protocols and Patient group Directions (PGDs)
Visit gov.im/pgd to access the latest Patient Group Directions for COVID-19.
For the administration of COVID-19 vaccines to individuals in accordance with the national COVID-19 vaccination programme.
National protocol for Comirnaty® COVID-19 mRNA vaccine (gov.uk)
7 January 2022
National protocol for Spikevax (formerly COVID-19 Vaccine Moderna)
17 December 2021
National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) (gov.uk)
29 October 2021
National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) (gov.uk)
20 November 2021
Programme documents
Independent report: 7 January 2022
JCVI statement on the adult COVID-19 booster vaccination programme and the Omicron variant
Independent report: 22 December 2021
JCVI update on advice for COVID-19 vaccination of children and young people
Independent report: 14 December 2021
Suspension of the 15-minute wait for vaccination with mRNA vaccine for COVID-19: UK CMOs' opinion
Independent report: 29 November 2021
UK vaccine response to the Omicron variant: JCVI advice
Independent report: 15 November 2021
COVID-19 vaccination in children and young people aged 16 to 17 years: JCVI statement, November 2021
Independent report: 15 November 2021
COVID-19 booster vaccine programme for winter 2021 to 2022: JCVI statement, November 2021
Independent report: 14 September 2021
JCVI statement, September 2021: COVID-19 booster vaccine programme for winter 2021 to 2022
Independent report: 1 September 2021
Third primary COVID-19 vaccine dose for people who are immunosuppressed: JCVI advice
Independent report: 4 August 2021
JCVI statement, August 2021: COVID-19 vaccination of children and young people aged 12 to 17 years
Independent report: 19 July 2021
COVID-19 vaccination of children and young people aged 12 to 17 years: JCVI statement
Independent report: 7 May 2021
Use of the AstraZeneca COVID-19 vaccine: JCVI statement, 7 May 2021
Independent report: 13 April 2021
Priority groups for phase 2 of the coronavirus (COVID-19) vaccination programme: advice from the JCVI
Independent report: 7 April 2021
Use of the AstraZeneca COVID-19 vaccine: JCVI statement
Independent report: 11 March 2021
Letter from the Health and Social Care Secretary on COVID-19 vaccination phase 1 advice
Correspondence: 26 January 2021
Prioritising the first COVID-19 vaccine dose: JCVI statement
Independent report: 6 January 2021
Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 30 December 2020
Independent report: 24 February 2021
Letter from the Health and Social Care Secretary on COVID-19 vaccination in people with learning disabilities
Correspondence: 20 January 2021
COVID-19 vaccinations and community-based social care workers
Correspondence: 13 January 2021
UK COVID-19 vaccines delivery plan
Policy paper: 31 December 2020
Letter to the profession from the UK Chief Medical Officers on the UK COVID-19 vaccination programmes
Correspondence: 4 December 2020
COVID-19 vaccinations and care homes: programme launch
Updated 18 January 2022
